Abstract:Background:: The research and development of HIV drugs is very important, but at the same time it is a long cycle and expensive system project. High-throughput drug screening systems and molecular libraries of potential hit compounds remain the main ways for the discovery of hit compounds with anti-HIV activity. Objective:: The aim of this study was to screen out the hit compounds against HIV-1 in the natural product molecule library and the antiviral molecule library, and elucidate the molecular mechanism of their inhibition of HIV-1, so as to provide a new choice for AIDS drug research. Methods:: In this study, a drug screening system using HIV Rev-dependent indicator cell line (Rev-A3R5-GFP reporter cells) with pseudoviruses (pNL4-3) was used. The natural drug molecule library and antiviral molecule library were screened, and preliminary drug mechanism studies were performed. Results:: Ten promising hit compounds were screened. These ten molecules and their drug inhibitory IC50 were as follows: Cephaeline (0.50 μM), Yadanziolide A (8.82 μM), Bruceine D (2.48 μM), Astragaloside IV (4.30 μM), RX-3117 (1.32 μM), Harringtonine (0.63 μM), Tubercidin (0.41 μM), Theaflavine-3, 3'-digallate (0.41 μM), Ginkgetin (10.76 μM), ZK756326 (5.97 μM). The results of the Time of additions showed that except for Astragaloside IV and Theaflavine-3, 3'-digallate had a weak entry inhibition effect, and it was speculated that all ten compounds had an intracellular inhibition effect. Cephaeline, Harringtonine, Astragaloside IV, Bruceine D, and Tubercidin may have pre-reverse transcriptional inhibition. Yadanziolide A, Theaflavine-3, 3'-digallate, Ginkgetin and RX-3117 may be in the post-reverse transcriptional inhibition. The inhibitory effect of ZK 75632 may be in the reverse transcriptional process. Conclusion:: A drug screening system using Rev-A3R5-GFP reporter cells with pseudoviruses (pNL4-3) is highly efficient. This study provided potential hit compounds for new HIV drug research.

Extracting Information Of Anti-Aids Inhibitor From The Biological Literature Based On Ontology

Construction of Antibiotics Knowledge Base for Clinical Management Based on Ontology

Approach for Semi-automatic Construction of Anti-infective Drug Ontology Based on Entity Linking

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

Research Status Quo and Development Trend of Anti - HIV Drugs

An Approach to Semantic Query Expansion System Based on Hepatitis Ontology

Ontology Based Information Extraction for Disease Intelligence

ONBIRES: Ontology-Based Biological Relation Extraction System

Ontology-based biomedical literature management for competitive analysis

Development and Validation of an AI‐Driven System for Automatic Literature Analysis and Molecular Regulatory Network Construction

Glucose lowering and cardiovascular disease: what do we know and what should we do?

PathwayFinder : Bridging the Way Towards Automatic Pathway Extraction

Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H

A Hybrid Method for Relation Extraction from Biomedical Literature

Models and Processes to Extract Drug-like Molecules From Natural Language Text

Biomedical Information Extraction for Disease Gene Prioritization

An Integrated Strategy for Functional Analysis in Large-scale Proteomic Research by Gene Ontology

AutoIE: An Automated Framework for Information Extraction from Scientific Literature

Structure and Anti-HIV Activity of Betulinic Acid Analogues

Effects of mixed volatile fatty acid sodium salt on insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-3 (IGFBP-3) in plasma and rumen tissue, and rumen epithelium development in lambs

Discovery of Ten Anti-HIV Hit Compounds and Preliminary Pharmacological Mechanisms Studies